Centaurus Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.09M | Buy |
8,150
+103
| +1% | +$49.4K | 0.16% | 142 |
|
|
2026
Q1 | $3.96M | Sell |
8,047
-40
| -0.5% | -$21.7K | 0.19% | 118 |
|
|
2025
Q4 | $4.69M | Sell |
8,087
-41
| -0.5% | -$23.2K | 0.21% | 102 |
|
|
2025
Q3 | $3.94M | Buy |
8,128
+952
| +13% | +$443K | 0.19% | 118 |
|
|
2025
Q2 | $2.91M | Buy |
7,176
+534
| +8% | +$223K | 0.17% | 136 |
|
|
2025
Q1 | $3.31M | Sell |
6,642
-13
| -0.2% | -$7.04K | 0.2% | 114 |
|
|
2024
Q4 | $3.46M | Buy |
6,655
+153
| +2% | +$84.1K | 0.21% | 103 |
|
|
2024
Q3 | $4.02M | Buy |
6,502
+219
| +3% | +$130K | 0.26% | 89 |
|
|
2024
Q2 | $3.48M | Buy |
6,283
+201
| +3% | +$115K | 0.23% | 102 |
|
|
2024
Q1 | $3.54M | Buy |
6,082
+151
| +3% | +$84.7K | 0.25% | 97 |
|
|
2023
Q4 | $3.15M | Buy |
5,931
+546
| +10% | +$264K | 0.24% | 97 |
|
|
2023
Q3 | $2.73M | Buy |
5,385
+831
| +18% | +$443K | 0.24% | 99 |
|
|
2023
Q2 | $2.38M | Sell |
4,554
-574
| -11% | -$310K | 0.21% | 124 |
|
|
2023
Q1 | $2.96M | Buy |
5,128
+549
| +12% | +$309K | 0.24% | 112 |
|
|
2022
Q4 | $2.52M | Sell |
4,579
-711
| -13% | -$377K | 0.24% | 112 |
|
|
2022
Q3 | $2.68M | Buy |
5,290
+397
| +8% | +$222K | 0.26% | 99 |
|
|
2022
Q2 | $2.66M | Sell |
4,893
-47
| -1% | -$25.9K | 0.26% | 102 |
|
|
2022
Q1 | $2.92M | Sell |
4,940
-180
| -4% | -$103K | 0.23% | 113 |
|
|
2021
Q4 | $3.42M | Sell |
5,120
-45
| -0.9% | -$28.1K | 0.26% | 97 |
|
|
2021
Q3 | $2.95M | Buy |
5,165
+91
| +2% | +$49.9K | 0.25% | 98 |
|
|
2021
Q2 | $2.56M | Buy |
5,074
+4,294
| +551% | +$2.03M | 0.22% | 116 |
|
|
2021
Q1 | $356K | Buy |
780
+95
| +14% | +$45.3K | 0.04% | 458 |
|
|
2020
Q4 | $319K | Sell |
685
-50
| -7% | -$23.4K | 0.03% | 454 |
|
|
2020
Q3 | $324K | Buy |
735
+193
| +36% | +$79.7K | 0.04% | 356 |
|
|
2020
Q2 | $196K | Buy |
542
+36
| +7% | +$12.1K | 0.03% | 427 |
|
|
2020
Q1 | $144K | Buy |
506
+11
| +2% | +$3.47K | 0.03% | 416 |
|
|
2019
Q4 | $161K | Buy |
+495
| New | +$150K | 0.02% | 503 |
|
|
2019
Q3 | – | Sell |
-1,008
| Closed | -$296K | – | 575 |
|
|
2019
Q2 | $296K | Buy |
1,008
+739
| +275% | +$204K | 0.05% | 356 |
|
|
2019
Q1 | $983 | Sell |
269
-11
| -4% | -$2.74K | 0.01% | 527 |
|
|
2018
Q4 | $1 | Buy |
280
+279
| +27,900% | +$65.5K | 0.01% | 460 |
|
|
2018
Q3 | $366 | Sell |
1
-1,498
| -100% | -$345K | 0.07% | 282 |
|
|
2018
Q2 | $311K | Buy |
1,499
+137
| +10% | +$29.1K | 0.04% | 409 |
|
|
2018
Q1 | $281K | Buy |
+1,362
| New | +$286K | 0.07% | 270 |
|
Other funds holding TMO
Centaurus Financial's TMO Position: Q2 2026 in Review
Centaurus Financial increased its Thermo Fisher Scientific (TMO) stake by 1.3% in Q2 2026, buying an estimated $49.4K and bringing the position to 8,150 shares worth $4.09M. The position accounts for 0.16% of the portfolio, ranked #142.
Centaurus Financial first reported a position in TMO in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.69M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Centaurus Financial held 8,150 shares of Thermo Fisher Scientific worth $4.09M as of Q2 2026.
- Centaurus Financial bought 103 Thermo Fisher Scientific shares in Q2 2026, an estimated $49.4K.
- Thermo Fisher Scientific made up 0.16% of Centaurus Financial's portfolio in Q2 2026, its #142 holding.
- Centaurus Financial first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 33 quarters since.
- Centaurus Financial's Thermo Fisher Scientific position peaked at $4.69M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.